Cees Vermeer Selected Research

Vitamin K 1 (Phylloquinone)

3/2022	Comment on Sobczyk, M.K.; Gaunt, T.R. The Effect of Circulating Zinc, Selenium, Copper and Vitamin K1 on COVID-19 Outcomes: A Mendelian Randomization Study. Nutrients 2022, 14, 233.
1/2017	Circulating Vitamin K Is Inversely Associated with Incident Cardiovascular Disease Risk among Those Treated for Hypertension in the Health, Aging, and Body Composition Study (Health ABC).
8/2014	Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation.
2/2007	Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.
11/2006	Effect of calcium, vitamins K1 and D3 on bone in galactosemia.
11/2004	Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study.
9/2004	Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cees Vermeer Research Topics

Disease

44	Vascular Calcification 01/2022 - 01/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2004
8	Vitamin K Deficiency 11/2019 - 02/2011
6	Chronic Renal Insufficiency 01/2018 - 04/2010
5	Inflammation (Inflammations) 04/2022 - 08/2011
5	Coronary Disease (Coronary Heart Disease) 11/2021 - 11/2004
5	Atherosclerosis 01/2015 - 11/2004
4	Osteoarthritis 12/2020 - 08/2014
4	Hypertension (High Blood Pressure) 01/2018 - 09/2008
4	Hemorrhage 01/2018 - 04/2002
4	Chronic Disease (Chronic Diseases) 10/2017 - 10/2013
4	Vascular Diseases (Vascular Disease) 01/2016 - 07/2007
3	COVID-19 03/2022 - 01/2021
3	Thrombosis (Thrombus) 12/2021 - 06/2010
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 07/2019 - 10/2017
3	Heart Failure 01/2016 - 08/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015 - 04/2004
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2015 - 10/2010
3	Aortic Valve Stenosis (Aortic Stenosis) 07/2014 - 01/2008
3	Osteoporosis 05/2014 - 07/2007
3	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 04/2013 - 10/2007
2	Pneumonia (Pneumonitis) 12/2021 - 01/2021
2	Left Ventricular Dysfunction 01/2018 - 08/2011
2	Cystic Fibrosis (Mucoviscidosis) 10/2017 - 06/2003
2	Neoplasms (Cancer) 10/2017 - 01/2014
2	Calciphylaxis 06/2017 - 01/2008
2	Aortic Valve Disease 02/2015 - 10/2010
2	Uremia 08/2014 - 05/2003
2	Metabolic Bone Diseases (Osteopenia) 03/2007 - 06/2003
2	Hyperphosphatemia 05/2003 - 01/2002
1	Noncommunicable Diseases 02/2022
1	Varicose Veins (Varicose Vein) 12/2021
1	Hepatic Insufficiency 12/2021
1	of Schnyder Crystalline Corneal Dystrophy 03/2021
1	Thromboembolism 01/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Oligospermia (Oligozoospermia) 11/2019
1	Asthenozoospermia 11/2019
1	Stroke (Strokes) 01/2018
1	Myocardial Infarction 01/2018
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2018
1	Nephrolithiasis 01/2018
1	Pathologic Processes 10/2017
1	Bronchiectasis 10/2017

Drug/Important Bio-Agent (IBA)

49	Vitamin K FDA Link 01/2022 - 11/2004
46	Matrix Gla ProteinIBA 01/2022 - 01/2002
23	Proteins (Proteins, Gene)FDA Link 04/2022 - 05/2003
7	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 03/2022 - 09/2004
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2008
7	CalciumIBA 01/2018 - 01/2002
6	Vitamin K 2 (Vitamin K2)IBA 01/2016 - 11/2004
5	AntibodiesIBA 01/2018 - 08/2005
4	AnticoagulantsIBA 12/2021 - 04/2002
4	ElastinIBA 07/2019 - 11/2011
4	alpha-2-HS-GlycoproteinIBA 11/2013 - 06/2008
4	1-Carboxyglutamic Acid (1 Carboxyglutamic Acid)IBA 01/2008 - 11/2004
3	vitamin K1 hydroquinoneIBA 12/2021 - 04/2013
3	Prothrombin (Factor II)IBA 12/2021 - 01/2017
3	LipidsIBA 03/2021 - 06/2003
3	Warfarin (Coumadin)FDA LinkGeneric 11/2019 - 01/2012
3	Phosphates (Orthophosphate)IBA 01/2018 - 01/2002
3	Vitamin D FDA LinkGeneric 01/2017 - 02/2004
3	MineralsIBA 02/2015 - 05/2010
3	VitaminsIBA 05/2014 - 06/2003
3	OsteocalcinIBA 09/2012 - 07/2007
2	Blood Coagulation Factors (Coagulation Factor)IBA 12/2021 - 04/2016
2	Protein SIBA 12/2021 - 01/2021
2	CholesterolIBA 01/2020 - 07/2015
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017 - 03/2016
2	CreatinineIBA 01/2016 - 09/2008
2	menaquinone 7IBA 10/2015 - 09/2012
2	C-Reactive ProteinIBA 05/2015 - 08/2011
2	acarboxyprothrombin (PIVKA)IBA 01/2015 - 02/2011
2	Glutamic Acid (Glutamate)FDA Link 08/2011 - 10/2010
2	coumarinIBA 07/2007 - 04/2002
1	CopperIBA 03/2022
1	SeleniumIBA 03/2022
1	ZincIBA 03/2022
1	Greenhouse GasesIBA 02/2022
1	Protein Isoforms (Isoforms)IBA 12/2021
1	methyl beta-D-thiogalactopyranoside phosphateIBA 12/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Protective AgentsIBA 12/2020
1	amentadioneIBA 12/2020
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	LigandsIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	FatsIBA 04/2018
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018
1	AldosteroneIBA 01/2018
1	calcium phosphateIBA 01/2018

Therapy/Procedure

5	Renal Dialysis (Hemodialysis) 05/2019 - 01/2008
1	Lasers (Laser) 01/2020
1	Hemodiafiltration 05/2019
1	Therapeutics 11/2017